Chemotherapy Biotherapy Certification ONS Practice Test 2025 - Free Practice Questions and Study Guide

Biotherapy, also known as immunotherapy, is often utilized as adjuvant therapy in cancer treatment. This approach involves using biotherapeutic agents to enhance the body's immune response against cancer cells, providing additional support to primary treatment modalities such as chemotherapy or radiation.

Adjuvant therapy is administered after the primary treatment to reduce the risk of cancer recurrence. It aims to eliminate any remaining cancer cells that might not have been completely eradicated by initial treatment. By positioning biotherapy as an adjuvant option, it effectively leverages the immune system's capabilities while allowing for enhanced therapeutic efficacy when combined with conventional treatments.

While biotherapy can also be involved in palliative care or, in some circumstances, potentially curative settings, its primary role and widespread recognition within cancer treatment protocols often align with supporting patients post-primary treatment to improve overall outcomes and increase survival rates. This makes adjuvant therapy a pivotal aspect of biotherapy in oncological practice.